Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial

INTRODUCTION: Ventilator-associated pneumonia (VAP) is the first cause of healthcare-associated infections in intensive care units (ICUs) and brain injury is one of the main risk factors for early-onset VAP. Antibiotic prophylaxis has been reported to decrease their occurrence in brain-injured patie...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:BMJ Open
Κύριοι συγγραφείς: Dahyot-Fizelier, Claire, Frasca, Denis, Lasocki, Sigismond, Asehnoune, Karim, Balayn, Dorothée, Guerin, Anne-Laure, Perrigault, Pierre-François, Geeraerts, Thomas, Seguin, Philippe, Rozec, Bertrand, Elaroussi, Djilali, Cottenceau, Vincent, Guyonnaud, Clément, Mimoz, Olivier
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BMJ Publishing Group 2018
Θέματα:
Intensive Care
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196869/
https://ncbi.nlm.nih.gov/pubmed/30341115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-021488
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια